Cargando…

High Density Lipoprotein Particle Size in Children: Relation to Atherogenic Dyslipidemia

Atherosclerosis begins in childhood. Protection from atherosclerosis is provided by high-density lipoprotein (HDL), a heterogeneous particle, which includes several subclasses differing in size, density and apolipoprotein content. The objective of this study was to document the relevance of assessin...

Descripción completa

Detalles Bibliográficos
Autor principal:	Numata, Michio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society for Pediatric Endocrinology 2004
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4004907/ https://www.ncbi.nlm.nih.gov/pubmed/24790291 http://dx.doi.org/10.1297/cpe.13.1

Ejemplares similares

Atherogenic dyslipidemia
por: Manjunath, C. N., et al.
Publicado: (2013)

Streptococcus pneumoniae pneumolysin and neuraminidase A convert high-density lipoproteins into pro-atherogenic particles
por: Syed, Shahan, et al.
Publicado: (2021)

Prevalence and Predictors of Atherogenic Serum Lipoprotein Dyslipidemia in Women with Obstructive Sleep Apnea
por: Xia, Yunyan, et al.
Publicado: (2017)

Atherogenic Dyslipidemia and Cardiovascular Risk Factors in Obese Children
por: D'Adamo, Ebe, et al.
Publicado: (2015)

Atherogenic Plasma Index or Non-High-Density Lipoproteins as Markers Best Reflecting Age-Related High Concentrations of Small Dense Low-Density Lipoproteins
por: Płaczkowska, Sylwia, et al.
Publicado: (2022)

Atherogenic Dyslipidemia in Children: Evaluation of Clinical, Biochemical and Genetic Aspects
por: Montali, Anna, et al.
Publicado: (2015)

Cardioprotective Effects of High-Density Lipoprotein Beyond its Anti-Atherogenic Action
por: Nagao, Manabu, et al.
Publicado: (2018)

The Effect of Insulin Resistance and Obesity on Low−Density Lipoprotein Particle Size in Children
por: Taşcılar, Mehmet Emre, et al.
Publicado: (2010)

The Relationship between Daily Fructose Consumption and Oxidized Low-Density Lipoprotein and Low-Density Lipoprotein Particle Size in Children with Obesity
por: Gungor, Ali, et al.
Publicado: (2021)

Cholesterol Forms and Traditional Lipid Profile for Projection of Atherogenic Dyslipidemia: Lipoprotein Subfractions and Erythrocyte Membrane Cholesterol
por: Uydu, Hüseyin Avni, et al.
Publicado: (2013)

Statins but not fibrates improve the atherogenic to anti-atherogenic lipoprotein particle ratio: a randomized crossover study
por: Chan, Sammy Y, et al.
Publicado: (2008)

Adipocyte Triglyceride Turnover Is Independently Associated With Atherogenic Dyslipidemia
por: Frayn, Keith, et al.
Publicado: (2012)

Search for genetic factors predisposing to atherogenic dyslipidemia
por: Yip, Agustin G, et al.
Publicado: (2003)

Atherogenic Dyslipidemia: Cardiovascular Risk and Dietary Intervention
por: Musunuru, Kiran
Publicado: (2010)

Oxidative Stress, Atherogenic Dyslipidemia, and Cardiovascular Risk
por: Vekic, Jelena, et al.
Publicado: (2023)

Atherogenic Lipoprotein Determinants of Cardiovascular Disease and Residual Risk Among Individuals With Low Low‐Density Lipoprotein Cholesterol
por: Lawler, Patrick R., et al.
Publicado: (2017)

Small Dense Low‐Density Lipoprotein Cholesterol Is the Most Atherogenic Lipoprotein Parameter in the Prospective Framingham Offspring Study
por: Ikezaki, Hiroaki, et al.
Publicado: (2021)

Correction: Atherogenic Dyslipidemia in Children: Evaluation of Clinical, Biochemical and Genetic Aspects
por: Montali, Anna, et al.
Publicado: (2015)

Prevalence of dyslipidemia, atherogenic and cardiovascular risk in overweight and obese adolescents
por: de Andrades, Clara dos Santos, et al.
Publicado: (2023)

Erratum to: Cholesterol Forms and Traditional Lipid Profile for Projection of Atherogenic Dyslipidemia: Lipoprotein Subfractions and Erythrocyte Membrane Cholesterol
por: Uydu, Hüseyin Avni, et al.
Publicado: (2014)

AMPK activation enhances the anti-atherogenic effects of high density lipoproteins in apoE(−/−) mice
por: Ma, Ang, et al.
Publicado: (2017)

On the pathogenesis of atherosclerosis: enzymatic transformation of human low density lipoprotein to an atherogenic moiety
Publicado: (1995)

Hibernating brown bears are protected against atherogenic dyslipidemia
por: Giroud, Sylvain, et al.
Publicado: (2021)

Patients with Rheumatoid Arthritis Show Altered Lipoprotein Profiles with Dysfunctional High-Density Lipoproteins that Can Exacerbate Inflammatory and Atherogenic Process
por: Kim, Jae-Yong, et al.
Publicado: (2016)

Apolipoprotein B and non-high-density lipoprotein cholesterol reveal a high atherogenicity in individuals with type 2 diabetes and controlled low-density lipoprotein-cholesterol
por: Fonseca, Liliana, et al.
Publicado: (2020)

Associations between high density lipoprotein mean particle size and serum paraoxonase-1 activity
por: Razavi, Amirnader Emami, et al.
Publicado: (2012)

The Role of the Low-Density Lipoprotein/High-Density Lipoprotein Cholesterol Ratio as an Atherogenic Risk Factor in Young Adults with Ischemic Stroke: A Case—Control Study
por: Ciplak, Sibel, et al.
Publicado: (2023)

Fasting Serum Triglyceride and High-Density Lipoprotein Cholesterol Levels in Patients Intended to be Treated for Dyslipidemia
por: Kolovou, Genovefa D, et al.
Publicado: (2005)

Anorexia Nervosa Is Associated with a Shift to Pro-Atherogenic Low-Density Lipoprotein Subclasses
por: Stadler, Julia T., et al.
Publicado: (2022)

Glycative Stress, Glycated Hemoglobin, and Atherogenic Dyslipidemia in Patients with Hyperlipidemia
por: Yao, Chien-An, et al.
Publicado: (2023)

The effects of weight gain after smoking cessation on atherogenic α1-antitrypsin–low-density lipoprotein
por: Komiyama, Maki, et al.
Publicado: (2014)

Predictive value of atherogenic index of plasma and atherogenic index of plasma combined with low-density lipoprotein cholesterol for the risk of acute myocardial infarction
por: Chen, Min, et al.
Publicado: (2023)

Adiponectin and Lipoprotein Particle Size
por: Weiss, Ram, et al.
Publicado: (2009)

Effects of a very high saturated fat diet on LDL particles in adults with atherogenic dyslipidemia: A randomized controlled trial
por: Chiu, Sally, et al.
Publicado: (2017)

Atherogenic Index and High-Density Lipoprotein Cholesterol as Cardiovascular Risk Determinants in Rheumatoid Arthritis: The Impact of Therapy with Biologicals
por: Popa, Calin D., et al.
Publicado: (2012)

High-density lipoprotein (HDL) particle size and concentration changes in septic shock patients
por: Tanaka, Sébastien, et al.
Publicado: (2019)

Association between Wakeup Frequency at Night and Atherogenic Dyslipidemia: Evidence for Sex Differences
por: Yao, Chien-An, et al.
Publicado: (2023)

Atherogenic dyslipidemia and diabetes mellitus: what’s new in the management arena?
por: Kumar, Ajoy, et al.
Publicado: (2010)

Atherogenic Dyslipidemia and Residual Vascular Risk in Practice of Family Doctor
por: Alibasic, Esad, et al.
Publicado: (2015)

High-Risk Atherosclerosis and Metabolic Phenotype: The Roles of Ectopic Adiposity, Atherogenic Dyslipidemia, and Inflammation
por: Lechner, Katharina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8fsb68em2oo2b49umgrhch6r2s